In the present study, TOP2A vaccination was started before cancer development in C3(1)/Tag mice (Fig. 1d), and the vaccine effectively inhibited the tumor volume as compared with the adjuvant control (Fig. 1e). This evidence concerns the gene TOP2A and cancer.